Relationship between in vitro chromosomal radiosensitivity of peripheral blood lymphocytes and the expression of normal tissue damage following radiotherapy for breast cancer

Radiotherapy and Oncology

Volumn 55, Issue 2, 2000, Pages 179-186

  Barber, James B P ^a   Burrill, Wayne ^a   Spreadborough, Anne R ^a   Levine, Ed ^a   Warren, Coleen ^a   Kiltie, Anne E ^a   Roberts, Steve A ^a   Scott, David ^a  

^a CHRISTIE HOSPITAL   (United Kingdom)

Author keywords

G2 sensitivity; Lymphocytes chromosomal radiosensitivity; Micronucleus assay; Normal tissues; Predictive assays; Radiotherapy

Indexed keywords

ADULT; AGED; ARTICLE; BREAST CANCER; CELL CYCLE PHASE; CHROMOSOME ABERRATION; FEMALE; HUMAN; HUMAN CELL; LYMPHOCYTE; MAJOR CLINICAL STUDY; MICRONUCLEUS TEST; PREDICTION; PRIORITY JOURNAL; RADIATION DOSE; RADIOSENSITIVITY; SKIN MANIFESTATION; TISSUE INJURY; TISSUE REACTION;

ADULT; AGE FACTORS; AGED; BREAST NEOPLASMS; CELL CYCLE PROTEINS; CHROMOSOMES, HUMAN; DNA-BINDING PROTEINS; FEMALE; HUMANS; LYMPHOCYTES; MICRONUCLEUS TESTS; MIDDLE AGED; PROTEIN-SERINE-THREONINE KINASES; RADIATION TOLERANCE; RADIOTHERAPY; TUMOR SUPPRESSOR PROTEINS;

EID: 0034194456     PISSN: 01678140     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0167-8140(99)00158-9     Document Type: Article

References (36)

1. Appleby JM, Barber JB, Levine E, et al. Absence of mutations in the ATM gene in breast cancer patients with severe responses to radiotherapy. Br. J. Cancer 1997;76:1546-1549.
2. Begg AC, Russell NS, Knaken H, Lebesque JV. Lack of correlation of human fibroblast radiosensitivity in vitro with early skin reactions in patients undergoing radiotherapy. Int. J. Radiat. Biol. 1993;64:393-405.
3. Bentzen S. Potential clinical impact of normal tissue intrinsic radiosensitivity testing. Radiother. Oncol. 1997;43:121-131.
4. Bentzen SM, Overgaard M. Early and late normal tissue injury after postmastectomy radiotherapy. Recent Results Cancer Res. 1993;130: 59-78.
5. Bentzen SM, Overgaard M. Relationship between early and late normal-tissue injury after postmastectomy radiotherapy. Radiother. Oncol. 1991;20:159-165.
6. Bentzen SM, Overgaard M, Overgaard J. Clinical correlations between late normal tissue endpoints after radiotherapy: implications for predictive assays of radiosensitivity. Eur. J. Cancer 1993;29a: 1373-1376.
7. Brock WA, Tucker SL, Geara FB, et al. Fibroblast radiosensitivity versus acute and late normal skin responses in patients treated for breast cancer. Int. J. Radiat. Oncol. Biol. Phys. 1995;32:1371-1379.
8. Burnet NG, Nyman J, Turesson I, et al. The relationship between cellular radiation sensitivity and tissue response may provide the basis for individualising radiotherapy schedules. Radiother. Oncol. 1994;33:228-238.
9. Dahlberg W, Little J. Response of dermal fibroblast cultures from patients with unusually svere responses to radiotherapy and from ataxia telangiectasia heterozygotes to fractionated radiation. Clin. Cancer Res. 1995;1:785-790.
10. Fenech M, Morley AA. Measurement of micronuclei in lymphocytes. Mutation Res. 1985;147:29-36.
11. Fitzgerald MG, Bean JM, Hegde SR, Unsal H, Macdonald DJ. Heterozygous ATM mutations do not contribute to early onset of breast cancer. Nat. Genet. 1997;15:307-309.
12. Geara FB, Peters LJ, Ang KK, Wike JL, Brock WA. Prospective comparison of in vitro normal cell radiosensitivity and normal tissue reactions in radiotherapy patients. Int. J. Radiat. Oncol. Biol. Phys. 1993;27:1173-1179.
13. Johansen J, Bentzen SM, Overgaard J, Overgaard M. Relationship between the in vitro radiosensitivity of skin fibroblasts and the expression of subcutaneous fibrosis, telangiectasia, and skin erythema after radiotherapy. Radiother. Oncol. 1996;40:101-109.
14. Johansen J, Streffer C, Fuhrmann C, et al. Radiosensitivity of normal fibroblasts from breast cancer patients assessed by the micronucleus and colony assays. Int. J. Radiat. Biol. 1998;73:671-678.
15. Jones LA, Scott D, Cowan R, Roberts SA. Abnormal radiosensitivity of lymphocytes from breast cancer patients with excessive normal tissue damage after radiotherapy: chromosome aberrations after low dose-rate irradiation. Int. J. Radiat. Biol. 1995;67:519-528.
16. Moody AM, Mayles WP, Bliss JM, et al. The influence of breast size on late radiation effects and association with radiotherapy dose inhomogeneity. Radiother. Oncol. 1994;33:106-112.
17. Nachtrab U, Oppitz U, Flentje M, Stopper H. Radiation-induced micronucleus formation in human skin fibroblasts of patients showing severe and normal tissue damage after radiotherapy. Int. J. Radiat. Biol. 1998;73:279-287.
18. Neubauer S, Dunst J, Gebhart E. The impact of complex chromosomal rearrangements on the detection of radiosensitivity in cancer patients. Radiother. Oncol. 1997;43:189-195.
19. Rached E, Schindler R, Beer KT, Vetterli D, Greiner RH. No predictive value of the micronucleus assay for patients with severe acute reaction of normal tissue after radiotherapy. Eur. J. Cancer 1998;34: 378-383.
20. Ribeiro G. Breast. In: Pointon R, editor. The radiotherapy of malignant disease, London: Springer, 1990. pp. 255-278.
21. Ribeiro GG, Magee B, Swindell R, Harris M, Banerjee SS. The Christie Hospital breast conservation trial: an update at 8 years from inception. Clin. Oncol. 1993;5:278-283.
22. Rubin P, Constine LSR, Fajardo LF, Phillips TL, Wasserman TH. EORTC Late Effects Working Group. Overview of late effects normal tissues (LENT) scoring system. Radiother. Oncol. 1995;35:9-10.
23. Russell NS, Grummels A, Hart AA, et al. Low predictive value of intrinsic fibroblast radiosensitivity for fibrosis development following radiotherapy for breast cancer. Int. J. Radiat. Biol. 1998;73:661-670.
24. Sanford KK, Parshad R, Price FM, et al. Enhanced chromatid damage in blood lymphocytes after G2 phase x irradiation, a marker of the ataxia-telangiectasia gene. J. Natl. Cancer Inst. 1990;82:1050-1054.
25. Scott D, Barber JBP, Spreadborough AR, Burrill W, Roberts SA. Increased chromosomal radiosensitivity in breast cancer patients: a comparison of two assays. Int. J. Radiat. Biol. 1999;75:1-10.
26. Scott D, Barber JB, Levine EL, Burrill W, Roberts SA. Radiation-induced micronucleus induction in lymphocytes identifies a high frequency of radiosensitive cases among breast cancer patients: a test for predisposition? Br. J. Cancer 1998;77:614-620.
27. Scott D, Spreadborough A, Levine E, Roberts SA. Genetic predisposition in breast cancer. Lancet 1994;344:1444.
28. Shayeghi M, Seal S, Regan J, et al. Heterozygosity for mutations in the ataxia telangiectasia gene is not a major cause of radiotherapy complications in breast cancer patients. Br. J. Cancer 1998;78:922-927.
29. Tucker SL, Geara FB, Peters LJ, Brock WA. How much could the radiotherapy dose be altered for individual patients based on a predictive assay of normal-tissue radiosensitivity? Radiother. Oncol. 1996;38:103-113.
30. Tucker SL, Turesson I, Thames HD. Evidence for individual differences in the radiosensitivity of human skin. Eur. J. Cancer 1992;28a:1783-1791.
31. Turesson I. Individual variation and dose dependency in the progression rate of skin telangiectasia. Int. J. Radiat. Oncol. Biol. Phys. 1990;19:1569-1574.
32. Turesson I, Nyman J, Holmberg E, Oden A. Prognostic factors for acute and late skin reactions in radiotherapy patients. Int. J. Radiat. Oncol. Biol. Phys. 1996;36:1065-1075.
33. Turesson I, Thames HD. Repair capacity and kinetics of human skin during fractionated radiotherapy: erythema, desquamation, and telangiectasia after 3 and 5 year's follow-up. Radiother. Oncol. 1989;15: 169-188.
34. Weeks DE, Paterson MC, Lange K, et al. Assessment of chronic gamma radiosensitivity as an in vitro assay for heterozygote identification of ataxia-telangiectasia. Radiat. Res. 1991;128:90-99.
35. West CM. Invited review: intrinsic radiosensitivity as a predictor of patient response to radiotherapy. Br. J. Radiol. 1995;68:827-837.
36. West CM, Elyan SA, Berry P, Cowan R, Scott D. A comparison of the radiosensitivity of lymphocytes from normal donors, cancer patients, individuals with ataxia-telangiectasia (A-T) and A-T heterozygotes. Int. J. Radiat. Biol. 1995;68:197-203.